DE510561T1 - Pharmazeutische zusammensetzungen fuer die orale, kutane und intravaginale anwendung in form eines schaums. - Google Patents
Pharmazeutische zusammensetzungen fuer die orale, kutane und intravaginale anwendung in form eines schaums.Info
- Publication number
- DE510561T1 DE510561T1 DE1992106739 DE92106739T DE510561T1 DE 510561 T1 DE510561 T1 DE 510561T1 DE 1992106739 DE1992106739 DE 1992106739 DE 92106739 T DE92106739 T DE 92106739T DE 510561 T1 DE510561 T1 DE 510561T1
- Authority
- DE
- Germany
- Prior art keywords
- compound according
- active ingredient
- salt
- foam
- combination
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000006260 foam Substances 0.000 title claims 4
- 239000008194 pharmaceutical composition Substances 0.000 title claims 2
- 150000003839 salts Chemical class 0.000 claims 8
- 239000004480 active ingredient Substances 0.000 claims 7
- 150000001875 compounds Chemical class 0.000 claims 7
- OMDMTHRBGUBUCO-IUCAKERBSA-N (1s,5s)-5-(2-hydroxypropan-2-yl)-2-methylcyclohex-2-en-1-ol Chemical compound CC1=CC[C@H](C(C)(C)O)C[C@@H]1O OMDMTHRBGUBUCO-IUCAKERBSA-N 0.000 claims 2
- 150000001413 amino acids Chemical class 0.000 claims 2
- 230000003110 anti-inflammatory effect Effects 0.000 claims 2
- CNBGNNVCVSKAQZ-UHFFFAOYSA-N benzydamine Chemical compound C12=CC=CC=C2C(OCCCN(C)C)=NN1CC1=CC=CC=C1 CNBGNNVCVSKAQZ-UHFFFAOYSA-N 0.000 claims 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 239000002904 solvent Substances 0.000 claims 2
- 239000011782 vitamin Substances 0.000 claims 2
- 229940088594 vitamin Drugs 0.000 claims 2
- 229930003231 vitamin Natural products 0.000 claims 2
- 235000013343 vitamin Nutrition 0.000 claims 2
- JJVXHDTWVIPRBZ-VKHMYHEASA-N (2r)-2-[carboxy(methyl)amino]-3-sulfanylpropanoic acid Chemical compound OC(=O)N(C)[C@@H](CS)C(O)=O JJVXHDTWVIPRBZ-VKHMYHEASA-N 0.000 claims 1
- UUTKICFRNVKFRG-WDSKDSINSA-N (4R)-3-[oxo-[(2S)-5-oxo-2-pyrrolidinyl]methyl]-4-thiazolidinecarboxylic acid Chemical compound OC(=O)[C@@H]1CSCN1C(=O)[C@H]1NC(=O)CC1 UUTKICFRNVKFRG-WDSKDSINSA-N 0.000 claims 1
- MBRHNTMUYWQHMR-UHFFFAOYSA-N 2-aminoethanol;6-cyclohexyl-1-hydroxy-4-methylpyridin-2-one Chemical group NCCO.ON1C(=O)C=C(C)C=C1C1CCCCC1 MBRHNTMUYWQHMR-UHFFFAOYSA-N 0.000 claims 1
- HWIMWAMLHNOMRW-UHFFFAOYSA-N 3-(cyclopropylmethyl)-7h-purine-2,6-dione Chemical compound O=C1NC(=O)C=2NC=NC=2N1CC1CC1 HWIMWAMLHNOMRW-UHFFFAOYSA-N 0.000 claims 1
- 229920000858 Cyclodextrin Polymers 0.000 claims 1
- 102100035472 DNA polymerase iota Human genes 0.000 claims 1
- 101001094672 Homo sapiens DNA polymerase iota Proteins 0.000 claims 1
- 244000098338 Triticum aestivum Species 0.000 claims 1
- 230000002378 acidificating effect Effects 0.000 claims 1
- 229940024606 amino acid Drugs 0.000 claims 1
- 230000000843 anti-fungal effect Effects 0.000 claims 1
- 229940121375 antifungal agent Drugs 0.000 claims 1
- 229960000333 benzydamine Drugs 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 229960004375 ciclopirox olamine Drugs 0.000 claims 1
- 239000003246 corticosteroid Substances 0.000 claims 1
- 229960001334 corticosteroids Drugs 0.000 claims 1
- 229940097362 cyclodextrins Drugs 0.000 claims 1
- 229960001259 diclofenac Drugs 0.000 claims 1
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 229960000890 hydrocortisone Drugs 0.000 claims 1
- 230000002519 immonomodulatory effect Effects 0.000 claims 1
- 229910052500 inorganic mineral Inorganic materials 0.000 claims 1
- DKYWVDODHFEZIM-UHFFFAOYSA-N ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 claims 1
- 229960000991 ketoprofen Drugs 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 239000011707 mineral Substances 0.000 claims 1
- 230000001569 mucosecretolytic effect Effects 0.000 claims 1
- NKDJNEGDJVXHKM-UHFFFAOYSA-N n,2-dimethyl-4,5,6,7-tetrahydroindazol-3-amine Chemical group C1CCCC2=NN(C)C(NC)=C21 NKDJNEGDJVXHKM-UHFFFAOYSA-N 0.000 claims 1
- 230000007935 neutral effect Effects 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 229940124531 pharmaceutical excipient Drugs 0.000 claims 1
- 229960001163 pidotimod Drugs 0.000 claims 1
- 229960002702 piroxicam Drugs 0.000 claims 1
- QYSPLQLAKJAUJT-UHFFFAOYSA-N piroxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=CC=CC=N1 QYSPLQLAKJAUJT-UHFFFAOYSA-N 0.000 claims 1
- 239000003380 propellant Substances 0.000 claims 1
- 230000003716 rejuvenation Effects 0.000 claims 1
- 229960000230 sobrerol Drugs 0.000 claims 1
- 239000004094 surface-active agent Substances 0.000 claims 1
- 229950006500 tetridamine Drugs 0.000 claims 1
- OMDMTHRBGUBUCO-UHFFFAOYSA-N trans-sobrerol Natural products CC1=CCC(C(C)(C)O)CC1O OMDMTHRBGUBUCO-UHFFFAOYSA-N 0.000 claims 1
- 230000029663 wound healing Effects 0.000 claims 1
Landscapes
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI911149A IT1247529B (it) | 1991-04-24 | 1991-04-24 | Composizioni farmaceutiche in forma di schiuma per somministrazione intravaginale, cutanea e orale |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE510561T1 true DE510561T1 (de) | 1993-04-08 |
Family
ID=11359784
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE1992106739 Pending DE510561T1 (de) | 1991-04-24 | 1992-04-21 | Pharmazeutische zusammensetzungen fuer die orale, kutane und intravaginale anwendung in form eines schaums. |
| DE1992612371 Expired - Lifetime DE69212371T2 (de) | 1991-04-24 | 1992-04-21 | Pharmazeutische Zusammensetzungen für die orale, kutane und intravaginale Anwendung in Form eines Schaums |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE1992612371 Expired - Lifetime DE69212371T2 (de) | 1991-04-24 | 1992-04-21 | Pharmazeutische Zusammensetzungen für die orale, kutane und intravaginale Anwendung in Form eines Schaums |
Country Status (5)
| Country | Link |
|---|---|
| AT (1) | ATE140623T1 (fr) |
| CA (1) | CA2066945C (fr) |
| CZ (1) | CZ283238B6 (fr) |
| DE (2) | DE510561T1 (fr) |
| RU (1) | RU2093146C1 (fr) |
-
1992
- 1992-04-21 AT AT92106739T patent/ATE140623T1/de active
- 1992-04-21 DE DE1992106739 patent/DE510561T1/de active Pending
- 1992-04-21 DE DE1992612371 patent/DE69212371T2/de not_active Expired - Lifetime
- 1992-04-23 CZ CS921239A patent/CZ283238B6/cs unknown
- 1992-04-23 CA CA 2066945 patent/CA2066945C/fr not_active Expired - Lifetime
- 1992-04-23 RU SU5011762 patent/RU2093146C1/ru active
Also Published As
| Publication number | Publication date |
|---|---|
| RU2093146C1 (ru) | 1997-10-20 |
| DE69212371T2 (de) | 1997-01-16 |
| ATE140623T1 (de) | 1996-08-15 |
| CZ283238B6 (cs) | 1998-02-18 |
| CA2066945A1 (fr) | 1992-10-25 |
| CS123992A3 (en) | 1992-11-18 |
| DE69212371D1 (de) | 1996-08-29 |
| CA2066945C (fr) | 2004-06-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0510561B1 (fr) | Compositions pharmaceutiques orales, cutanées et intravaginales sous forme de mousse | |
| US4661524A (en) | Topical treatment and composition | |
| AU776318B2 (en) | Topical zinc compositions and methods of use | |
| DE3382616T2 (de) | Vermittler des durchdringungsvermoegens zur transdermalen verabreichung systemischer wirkstoffe. | |
| AU633892B2 (en) | Moisturizing vehicle for topical application of vitamin a acid | |
| CA2628857A1 (fr) | Preparation et methode de traitement de neoplasmes par inhalation | |
| JP2006306899A (ja) | 抗刺激性酒さ治療 | |
| EP0692250B1 (fr) | Formulations contenant de l'esculoside et leur utilisation dans les domaines pharmaceutiques et cosmétiques | |
| CA2419404A1 (fr) | Compositions et methodes de traitement de dysfonctionnements sexuels | |
| EP1477166A1 (fr) | Utilisation du riluzole combiné avec des excipients et additifs pour le traitement de troubles charactérisés par un hyperprolifération de kératinocytes, notamment neurodermitis et psoriasis | |
| JP2023061951A (ja) | 皮膚障害の処置 | |
| JP2609564B2 (ja) | アレルギー性皮膚炎用クリーム及びその製造方法 | |
| ATE309816T1 (de) | Topisches arzneimittel mit einem gehalt an ciclosporin | |
| JPH1112136A (ja) | ミノキシジル配合エアゾール剤 | |
| DE510561T1 (de) | Pharmazeutische zusammensetzungen fuer die orale, kutane und intravaginale anwendung in form eines schaums. | |
| US5036050A (en) | Compositions containing thymopentin for topical treatment of skin disorders | |
| JPH03291221A (ja) | 皮膚外用液剤 | |
| DE69030584T2 (de) | Verfahren sowie zusammensetzungen zur behandlung mit vitaminmineral | |
| KR0137206B1 (ko) | 분무용 겔 기제와 이것을 사용한 분무용 겔제 | |
| HUP0002533A2 (hu) | Asztmaellenes gyógyszerhatóanyagok új kombinációja | |
| JP2005314434A (ja) | 生物におけるヒスタミン放出に関連する徴候を減じるための一のキレート剤を含む組成物の使用 | |
| JPH0899877A (ja) | 重感染に対する、脂肪酸及び脂肪酸グリセリドの含有物を含む皮膚科学的製剤 | |
| JPH04300833A (ja) | プロスタグランジンｅ１ 含有脂肪乳剤充填噴霧剤 | |
| JPH045221A (ja) | 口腔用組成物 | |
| CA2259270A1 (fr) | Preparation pharmaceutique contenant du nimesulide pour administration orale |